GSK

News

AZ shares slide after warning over coronavirus impact

Shares in AstraZeneca were sharply down this morning after it warned that the hit from the COVID-19 coronavirus could have an impact lasting a few months.

News

GSK licenses TB vaccine to Bill and Melinda Gates Institute

GlaxoSmithKline has licensed its potential tuberculosis vaccine to the Bill and Melinda Gates Medical Research Institute, saying this is the best way for it to be developed for low-income c

Views & Analysis

GSK finds synergies with global marketing strategy

GSK has shifted towards a global marketing model influenced by a Netflix-style approach that aims to match content to the person receiving it.

Views & Analysis

ESMO 2019 roundup

The European Society for Medical Oncology (ESMO) is growing in stature, with an increasing number of oncology-focused pharma companies choosing it as a forum to reveal their latest studies.

News

GSK aims to get triple therapy approved for asthma in US

GlaxoSmithKline and development partner Innoviva have filed a dossier with the FDA, in a bid to get their triple therapy approved to keep asthma at bay.

Views & Analysis

How to make digital adoption a smooth journey

Four big pharma experts explain the challenges companies face in adopting digital tech and what trends are likely to drive digital commercial strategies in the next few years.

AZ shares slide after warning over coronavirus impact

GSK licenses TB vaccine to Bill and Melinda Gates Institute

GSK finds synergies with global marketing strategy

ESMO 2019 roundup

GSK aims to get triple therapy approved for asthma in US

How to make digital adoption a smooth journey

Europe is facing a surge in STIs, says ECDC

Discover a new era of healthcare panel engagement: Grounded ...

GSK

Editor's Picks